Opinion

Video

Non-Statin Therapies: Cost Effectiveness and Clinical Evidence Gaps

Author(s):

Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPSAQ Cardiology, CACP,Kate Cabral, PharmD, BCCP, FACC, FCCP

The expert panel discusses the cost-effectiveness and clinical evidence gaps for non-statin therapies, including PCSK9 inhibitors, inclisiran, and bempedoic acid.

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!
Related Videos
Tired scared retiree man holding chest with anginal symptoms, pallor and diaphoresis at home. Suffering male with cardiac origin pain, prexcordial pressure, arrhythmia risk, urgent medical attention - Image credit: DimaBerlin | stock.adobe.com
5 experts in this video
Image credit: Sebastian Kaulitzki | stock.adobe.com
5 experts in this video
5 experts in this video
5 experts in this video
Related Content
Heart-healthy foods -- Image credit: marilyn barbone | stock.adobe.com
June 11th 2025

The Role of Pharmacists in Cardiovascular Health: A Collaborative Approach to Treatment, Counseling, and Nutrition

Megan Smith, PharmD
New Programs Aim to Improve Implementation of Cardiovascular Interventions
June 3rd 2025

New Programs Aim to Improve Implementation of Cardiovascular Interventions

Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPSAQ Cardiology, CACP Aislinn Antrim, Managing Editor
NLA 2025: Bempedoic Acid Supports ASCVD Prevention and LDL-C Reduction
June 2nd 2025

NLA 2025: Bempedoic Acid Supports ASCVD Prevention and LDL-C Reduction

Steven E. Nissen, MD, MACC Alana Hippensteele, Lead Editor
Pharmacist Involvement in Clinical Research and the FINEARTS-HF Trial
May 20th 2025

Pharmacist Involvement in Clinical Research and the FINEARTS-HF Trial

Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPSAQ Cardiology, CACP Aislinn Antrim, Managing Editor
FDA approval of treprostinil (Yutrepia) -- Image credit: Pakin | stock.adobe.com
May 27th 2025

FDA Approves Treprostinil Inhalation Powder for PAH and PH-ILD

Gillian McGovern, Associate Editor
AI-generated depiction of a heart -- Image credit: Vasili | stock.adobe.com
May 26th 2025

GADD45A May Prevent Inflammation, Fibrosis, and Preserve Cardiac Function

Gillian McGovern, Associate Editor